FDA Inspection 1070030 — Regis Peffault de Latour, M.D.
The FDA completed an inspection of Regis Peffault de Latour, M.D. on September 28, 2018 in Paris Cedex 10. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 28, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Paris Cedex 10 (France)
Additional Details
Clinical Investigator (CI)